Why aXichem stock moves
aXichem rose slightly, without company news.
Written after the close on ·
Why today
16,415 news analyzed todayaXichem rose slightly, without company news.
No company news explains the move, which was an ordinary day for the stock.
Over the last five trading days it also rose slightly, a little ahead of OMX Stockholm 30.
Earlier news about seasonal return patterns is only background and not a cause.
The next earnings report is on Thursday 26 November 2026.
Today's move of +1.17% was 0.4 times a normal day's 2.9%. OMX Stockholm 30 moved −0.32% on the same day.
aXichem +1.17%OMX Stockholm 30 −0.32%Against the market
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +53% and earnings per share went from -0.46 SEK to -0.30 SEK.
Revenue, profit and market cap
RevenueProfitMarket capm SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capm SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 116 m SEKRevenue 2025: 18.4 m SEK
What the key figures say about aXichem
The figures connect what aXichem earns with what investors pay.
The line shows the share price in the same year, on its own scale.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -1.02 SEK–-0.30 SEK. Peers: Polygiene Group -0.27 SEK, Nexam Chemical Holding -0.16 SEK, Hove 0.81 DKK.
What the company sold during the year.
2022–2025: 1.8 m SEK–18.4 m SEK. Peers: Polygiene Group 126 m SEK, Nexam Chemical Holding 189 m SEK, Hove 251 m DKK.
The percentage of revenue left after the costs of running the business.
2022–2025: −957.3%–−94.8%. Peers: Polygiene Group −4.1%, Nexam Chemical Holding −8.5%, Hove 10.6%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −42.9%–−25.4%. Peers: Polygiene Group −3.3%, Nexam Chemical Holding −9.8%, Hove 23.1%.
What investors pay for each unit the company sells.
2022–2025: 6.68–49.47. Peers: Polygiene Group 0.75, Nexam Chemical Holding 1.36, Hove 0.71.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.15–5.95. Peers: Polygiene Group 0.33, Nexam Chemical Holding 1.26, Hove 1.85.
Cash left after investments, divided by the number of shares.
2022–2025: -1.24 SEK–-0.27 SEK. Peers: Polygiene Group -0.17 SEK, Nexam Chemical Holding -0.14 SEK, Hove 0.25 DKK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 65.8%–94.4%.
What to watch next, and why
The earnings report shows how aXichem's revenue and profit have changed.
- Earnings report
The earnings report shows how aXichem's revenue and profit have changed.
Add to calendar
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 16 report days aXichem usually moved about 3.4%. On a normal day it moves 2.9%.
−11.15% +2.68% −3.73% +2.59%
10,000 SEK in aXichem bought on November 7, 2016 is worth 2,800 SEK today, with dividends reinvested.
What would 10,000 SEK in aXichem be worth today? →
What would 10,000 SEK in aXichem be worth today?
2,800 SEK
with dividends reinvested, bought on November 7, 2016.
At worst it was worth 1,720 SEK (April 9, 2025).
The five biggest days of the journey
· +78.5% · the whole market rose 0.4% the same day
· −63.6% · the whole market rose 1.8% the same day
· −46.4% · the whole market rose 0.1% the same day
· −39.8% · the whole market rose 0.2% the same day · report day
· −34.6% · the whole market rose 0.7% the same day · report day
Earlier days
−1.99% market −0.11% aXichem was roughly unchanged over the week's trading days. Read →
aXichem was roughly unchanged over the week's trading days.
The market, OMX Stockholm 30, was also roughly flat, so aXichem moved in line with it.
The move was ordinary for the stock, and trading was well below its usual level.
The news list shows only seasonal return chart pages, not a company event, so no specific cause can be named.
−6.83% market +0.83% aXichem fell sharply without company news explaining it. Read →
aXichem fell sharply without company news explaining it.
Over the last five trading days it was roughly unchanged, while OMX Stockholm 30 rose slightly, so it moved less than the market.
The sharp fall moved against a rising market, and no company news from that session explains it. aXichem had an order of about 1.2 MSEK for its aXivite ingredient reported on 14 October, which is background only.
Its next earnings report is on Thursday 26 November 2026, a date to watch.
−4.69% market −0.08% aXichem fell, moving while the market was flat. Read →
aXichem fell, moving while the market was flat.
No company news explains the drop.
Over the last five trading days the stock rose slightly, a bit more than the market.
The stock sits well below its high of the past year and well above its low.
Peers and the sector in Basic Materials dipped about two percent over the same days, so the wider mood was soft.
+9.40% market +0.48% aXichem rose, clearly ahead of the market. Read →
aXichem rose, clearly ahead of the market.
No company news explains the move.
Over the last five trading days, aXichem also rose clearly, well ahead of OMX Stockholm 30, which rose only modestly.
Earlier, in mid-October, aXichem reported a SEK 1.2 million order for its aXivite ingredient through a US network-marketing partner, with delivery planned in the fourth quarter.
+4.15% market −0.29% aXichem rose, while OMX Stockholm 30 fell slightly. Read →
aXichem rose, while OMX Stockholm 30 fell slightly.
No company news explains the move, as aXichem has had no company news in the past two weeks.
Over the last five trading days the stock fell clearly, while the market rose clearly.
Its latest price sits well below its high of the past year and well above its low.
An earlier order for aXivite from a US distributor, announced in mid-October, is background only.
−7.63% market +3.01% aXichem fell clearly over the week's trading days, moving against a market that rose clearly. aXichem has had no company news in the past two weeks, so the move is not tied to a specific announcement. Read →
aXichem fell clearly over the week's trading days, moving against a market that rose clearly. aXichem has had no company news in the past two weeks, so the move is not tied to a specific announcement.
The weak Basic Materials sector, where peer stocks also sold off, likely weighed on the shares.
The company's next earnings report is due on 26 November 2026.
+0.00% market +0.96% aXichem moved without without company news. Read →
aXichem moved without without company news.
Over the last five trading days it fell clearly while the market was roughly flat.
The move was an ordinary size for aXichem, and trading was well below its usual level. aXichem has had no company news in the past two weeks.
Its order news from mid-October is background only.
−7.89% market +1.57% aXichem fell sharply without a company-news explanation. Read →
aXichem fell sharply without a company-news explanation.
aXichem is listed on Nasdaq Stockholm.
In the last session the stock fell sharply while OMX Stockholm 30 rose clearly, so it moved against the market.
Over the last five trading days aXichem fell clearly, while OMX Stockholm 30 fell slightly.
Trading was heavy, about three times a normal session.
+3.26% market −3.67% aXichem rose slightly over the last five trading days, while the broader market fell sharply. Read →
aXichem rose slightly over the last five trading days, while the broader market fell sharply.
The main news was a 1.2 million SEK order for its aXivite supplement ingredient from a US contract manufacturer serving a fast-growing direct-selling company.
It was the first order in the US network-marketing channel, with delivery planned in the fourth quarter.
Such a small order is unlikely to move the share much alone.
+0.00% market −2.51% aXichem was roughly unchanged, with no company news explaining it. Read →
aXichem was roughly unchanged, with no company news explaining it.
In the last session it moved far less than the market, which fell sharply, so it held up well against the market.
Over the last five trading days aXichem rose slightly while OMX Stockholm 30 fell clearly, so it moved against the market.
The main recent company news was an order of about 1.2 MSEK for aXivite, delivery planned in Q4, announced last Wednesday.
The move was an ordinary one for aXichem, and trading volume was well below its usual level.
+1.05% market −0.89% aXichem rose slightly, moving against a falling market. Read →
aXichem rose slightly, moving against a falling market.
No company news explains this move from that session.
Over the last five trading days the shares were roughly unchanged and moved less than OMX Stockholm 30, which fell slightly.
Delivery is planned for the fourth quarter.
+3.53% market −0.89% aXichem rose on Monday without company news. Read →
aXichem rose on Monday without company news.
Over the last five trading days, aXichem was roughly unchanged, and so was the OMX Stockholm 30 index.
The last session was different: aXichem rose clearly while the broader market fell clearly, so the move was company-specific rather than market-driven.
No company news came out in the last session, so no announcement explains the rise.
The most recent news dates from last Wednesday and Thursday.
Learn more · Why do stocks go up and down?